Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva M Riedmann

Showing results (31-40 of 95) with videos related to

Pageof 10
Sort By:
Human Vaccines & Immunotherapeutics|August 28, 2013
Ovarian cancer vaccine candidate DPX-Survivac: positive interim results from phase 1Eva M Riedmann
Human Vaccines & Immunotherapeutics|August 28, 2013
Chinese biotech partnership brings first hepatitis E vaccine to the marketEva M Riedmann
Human Vaccines & Immunotherapeutics|January 13, 2015
The latest on PaxVax’ and Gotovax AB’s cholera vaccine candidatesEva M Riedmann
Human Vaccines & Immunotherapeutics|November 15, 2014
New glioblastoma vaccine: safe and immunogenic in phase 1Eva M Riedmann
Human Vaccines & Immunotherapeutics|November 15, 2014
FDA approves sublingual hay fever immunotherapeuticEva M Riedmann
Human Vaccines & Immunotherapeutics|November 15, 2014
Two meningococcal B vaccines receive FDA 'breakthrough therapy' designationEva M Riedmann
Human Vaccines & Immunotherapeutics|November 15, 2014
MERS vaccine is technically feasible, but is it commerically feasible?Eva M Riedmann
Human Vaccines & Immunotherapeutics|June 26, 2014
Influenza vaccines prevented over 6 million flu cases in the USEva M Riedmann
Human Vaccines & Immunotherapeutics|June 26, 2014
Influenza vaccine effectiveness boosted by near-infrared laser lightEva M Riedmann
Human Vaccines & Immunotherapeutics|June 26, 2014
Vical initiates vaccine trials against HSV-2 and CMVEva M Riedmann
Pageof 10

Showing results (31-40 of 95) with videos related to

Sort By:
Pageof 10
Human Vaccines & Immunotherapeutics|August 28, 2013
Ovarian cancer vaccine candidate DPX-Survivac: positive interim results from phase 1Eva M Riedmann
Human Vaccines & Immunotherapeutics|August 28, 2013
Chinese biotech partnership brings first hepatitis E vaccine to the marketEva M Riedmann
Human Vaccines & Immunotherapeutics|January 13, 2015
The latest on PaxVax’ and Gotovax AB’s cholera vaccine candidatesEva M Riedmann
Human Vaccines & Immunotherapeutics|November 15, 2014
New glioblastoma vaccine: safe and immunogenic in phase 1Eva M Riedmann
Human Vaccines & Immunotherapeutics|November 15, 2014
FDA approves sublingual hay fever immunotherapeuticEva M Riedmann
Human Vaccines & Immunotherapeutics|November 15, 2014
Two meningococcal B vaccines receive FDA 'breakthrough therapy' designationEva M Riedmann
Human Vaccines & Immunotherapeutics|November 15, 2014
MERS vaccine is technically feasible, but is it commerically feasible?Eva M Riedmann
Human Vaccines & Immunotherapeutics|June 26, 2014
Influenza vaccines prevented over 6 million flu cases in the USEva M Riedmann
Human Vaccines & Immunotherapeutics|June 26, 2014
Influenza vaccine effectiveness boosted by near-infrared laser lightEva M Riedmann
Human Vaccines & Immunotherapeutics|June 26, 2014
Vical initiates vaccine trials against HSV-2 and CMVEva M Riedmann
Pageof 10